Relmada Therapeutics Inc banner

Relmada Therapeutics Inc
F:4E2

Watchlist Manager
Relmada Therapeutics Inc Logo
Relmada Therapeutics Inc
F:4E2
Watchlist
Price: 3.22 EUR 1.9% Market Closed
Market Cap: €96.9m

DCF Value

The DCF Value for Relmada Therapeutics Inc (4E2) under the Base Case is 2.78 EUR. Compared with the current market price of 3.22 EUR, the stock appears Overvalued by 14% .

Key assumptions
DCF Value
Base Case
€2.78
Overvaluation 14%
DCF Value
Price €3.22
Explore More DCF Valuations

Reverse DCF

Single-Assumption Reverse DCF
Stress-test one driver at a time